Terms: = Head and neck cancer AND BCOR, ANOP2, 54880, ENSG00000183337, MAA2, MCOPS2, FLJ38041, KIAA1575, MGC131961, FLJ20285, MGC71031 AND Treatment
4 results:
1. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
2. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
Haberecker M; Töpfer A; Melega F; Moch H; Pauli C
Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438
[TBL] [Abstract] [Full Text] [Related]
3. bcor-CCNB3 sarcoma arising in the pharynx.
Eguchi K; Omura G; Shimoi T; Kageyama D; Igaki H; Abe Y; Watanabe T; Aihara Y; Sakai A; Matsumoto Y; Sakai T; Yonemori K; Mori T; Yoshida A; Yoshimoto S
Auris Nasus Larynx; 2023 Aug; 50(4):618-622. PubMed ID: 35545465
[TBL] [Abstract] [Full Text] [Related]
4. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
